Universidad Peruana Cayetano Heredia

Feasibility Findrisc Score as a Complement to the Oral Glucose Tolerance Test to the Diagnostic of Type 2 Diabetes in a Military Hospital

Mostrar el registro sencillo del ítem

dc.contributor.author Yauck, LV
dc.contributor.author Lizarzaburu-Robles, JC
dc.contributor.author Villanes, S
dc.contributor.author Valera, J
dc.contributor.author Rosas, Moisés
dc.contributor.author Seclen Santisteban, Segundo Nicolas
dc.coverage.spatial Lima, Perú
dc.date.accessioned 2023-09-06T20:45:08Z
dc.date.available 2023-09-06T20:45:08Z
dc.date.issued 2023
dc.identifier.uri https://hdl.handle.net/20.500.12866/14064
dc.description.abstract Background: The prevalence of type 2 diabetes (T2D) is increasing worldwide, due to its necessary early detection of undiagnosed DT2 patients, and to identify individuals at risk for developing T2D by a practical risk-scoring questionnaire using tools that permit early detection, especially who have more risk, one of that tool is FINDRISC. Objective: To describe the main risk factors for developing T2D at the Central Air Force Hospital in Military populations in Lima-Perú using the Finnish Diabetes Risk Score (FINDRISC). Methods: This is an observational, transversal and descriptive study, of military personnel who come to annual evaluation, all subjects (age ≥18 years) without known diabetes, were included. Individuals with more than≥ 13 points in the FINDRISC score were selected to perform an Oral Glucose Tolerance (OGTT), as a proof of gold standard for diagnoses T2D. Results: Out of 615 participants that were suitable for the study, 113 subjects with the FINDRISC ≥13 scores or higher were further examined with an OGTT, the percentage of screen-detected T2D was 27%, the prevalence of isolated IGF was 44%, isolated IGT 5% and IFG and IGT combined were 17%. Conclusion: The Findrisc score is a useful instrument of complement to the Oral Glucose Tolerance Test in the diagnosis of type 2 diabetes in high-risk patients. en_US
dc.language.iso eng
dc.publisher Elsevier
dc.relation.ispartofseries Metabolism-Clinical and Experimental
dc.rights info:eu-repo/semantics/restrictedAccess
dc.rights.uri https://creativecommons.org/licenses/by-nc-nd/4.0/deed.es
dc.subject Diabetes mellitus en_US
dc.subject prevention en_US
dc.subject Impaired Fasting Glucose en_US
dc.subject Impaired Glucose tolerance en_US
dc.subject Carbohydrate intolerance en_US
dc.subject FINDRISC en_US
dc.subject.mesh Diabetes mellitus
dc.subject.mesh Prevención de Enfermedades
dc.subject.mesh Estado Prediabético
dc.subject.mesh Intolerancia a la Glucosa
dc.subject.mesh Intolerancia a la Glucosa
dc.title Feasibility Findrisc Score as a Complement to the Oral Glucose Tolerance Test to the Diagnostic of Type 2 Diabetes in a Military Hospital en_US
dc.type info:eu-repo/semantics/article
dc.identifier.doi https://doi.org/10.1016/j.metabol.2023.155510
dc.subject.ocde https://purl.org/pe-repo/ocde/ford#3.02.18
dc.relation.issn 1532-8600


Ficheros en el ítem

Ficheros Tamaño Formato Ver

No hay ficheros asociados a este ítem.

Este ítem aparece en la(s) siguiente(s) colección(ones)

Mostrar el registro sencillo del ítem

info:eu-repo/semantics/restrictedAccess Excepto si se señala otra cosa, la licencia del ítem se describe como info:eu-repo/semantics/restrictedAccess

Buscar en el Repositorio


Listar

Panel de Control

Estadísticas